These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28578818)

  • 21. Assessment of hallucinations in Parkinson's disease using a novel scale.
    Wada-Isoe K; Ohta K; Imamura K; Kitayama M; Nomura T; Yasui K; Nakaso K; Nakashima K
    Acta Neurol Scand; 2008 Jan; 117(1):35-40. PubMed ID: 18095953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease clinical milestones and mortality.
    Gonzalez MC; Dalen I; Maple-Grødem J; Tysnes OB; Alves G
    NPJ Parkinsons Dis; 2022 May; 8(1):58. PubMed ID: 35550520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.
    Zhu K; van Hilten JJ; Putter H; Marinus J
    Mov Disord; 2013 Jun; 28(6):755-62. PubMed ID: 23520046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia.
    Gaare JJ; Skeie GO; Tzoulis C; Larsen JP; Tysnes OB
    Mov Disord; 2017 Feb; 32(2):241-245. PubMed ID: 27862270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pareidolia in Parkinson's disease without dementia: A positron emission tomography study.
    Uchiyama M; Nishio Y; Yokoi K; Hosokai Y; Takeda A; Mori E
    Parkinsonism Relat Disord; 2015 Jun; 21(6):603-9. PubMed ID: 25864093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
    Giladi N; Treves TA; Paleacu D; Shabtai H; Orlov Y; Kandinov B; Simon ES; Korczyn AD
    J Neural Transm (Vienna); 2000; 107(1):59-71. PubMed ID: 10809404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience of care home residents with Parkinson's disease: Reason for admission and service use.
    Walker RW; Palmer J; Stancliffe J; Wood BH; Hand A; Gray WK
    Geriatr Gerontol Int; 2014 Oct; 14(4):947-53. PubMed ID: 24320887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of dementia in an elderly population of Parkinson's disease patients: a 15-year population-based study.
    Perez F; Helmer C; Foubert-Samier A; Auriacombe S; Dartigues JF; Tison F
    Alzheimers Dement; 2012 Nov; 8(6):463-9. PubMed ID: 22651942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients.
    Hepp DH; da Hora CC; Koene T; Uitdehaag BM; van den Heuvel OA; Klein M; van de Berg WD; Berendse HW; Foncke EM
    Parkinsonism Relat Disord; 2013 Sep; 19(9):795-9. PubMed ID: 23706540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual Dysfunction in Parkinson's Disease.
    Armstrong RA
    Int Rev Neurobiol; 2017; 134():921-946. PubMed ID: 28805589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effect of age and severity on the risk of dementia in Parkinson's disease.
    Levy G; Schupf N; Tang MX; Cote LJ; Louis ED; Mejia H; Stern Y; Marder K
    Ann Neurol; 2002 Jun; 51(6):722-9. PubMed ID: 12112078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How common are complications of Parkinson's disease?
    Schrag A; Ben-Shlomo Y; Quinn N
    J Neurol; 2002 Apr; 249(4):419-23. PubMed ID: 11967646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key clinical milestones 15 years and onwards after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001.
    Constantinescu R; Eriksson B; Jansson Y; Johnels B; Holmberg B; Gudmundsdottir T; Renck A; Berglund P; Bergquist F
    Clin Neurol Neurosurg; 2017 Mar; 154():43-48. PubMed ID: 28113102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients.
    Auyeung M; Tsoi TH; Mok V; Cheung CM; Lee CN; Li R; Yeung E
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):607-11. PubMed ID: 22362919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hallucinations and Development of Dementia in Parkinson's Disease.
    Gryc W; Roberts KA; Zabetian CP; Weintraub D; Trojanowski JQ; Quinn JF; Hiller AL; Chung KA; Poston KL; Yang L; Hu SC; Edwards KL; Montine TJ; Cholerton BA
    J Parkinsons Dis; 2020; 10(4):1643-1648. PubMed ID: 32741842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hallucinations and psychosis in Parkinson's disease.
    Rabey JM
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S105-10. PubMed ID: 20123547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with drug-induced visual hallucinations in Parkinson's disease.
    Papapetropoulos S; Argyriou AA; Ellul J
    J Neurol; 2005 Oct; 252(10):1223-8. PubMed ID: 15834642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors.
    Balash Y; Peretz C; Leibovich G; Herman T; Hausdorff JM; Giladi N
    J Neurol; 2005 Nov; 252(11):1310-5. PubMed ID: 15895303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression.
    Brumm MC; Siderowf A; Simuni T; Burghardt E; Choi SH; Caspell-Garcia C; Chahine LM; Mollenhauer B; Foroud T; Galasko D; Merchant K; Arnedo V; Hutten SJ; O'Grady AN; Poston KL; Tanner CM; Weintraub D; Kieburtz K; Marek K; Coffey CS;
    J Parkinsons Dis; 2023; 13(6):899-916. PubMed ID: 37458046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.